These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12632513)

  • 1. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis.
    Zhang SC; Wang W; Ren WY; He BM; Zhou K; Zhu WN
    World J Gastroenterol; 2003 Mar; 9(3):534-8. PubMed ID: 12632513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats.
    Zhang S; Wang W; Ren W; Dai Q; He B; Zhou K
    Chin Med J (Engl); 2003 May; 116(5):767-71. PubMed ID: 12875698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of cisapride on intestinal bacterial and endotoxin translocation in cirrhotic rats].
    Zhang SC; Wang W; Ren WY; Zhou K; He BM; Zhu WN
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):539-41. PubMed ID: 14552714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis.
    Pardo A; Bartolí R; Lorenzo-Zúñiga V; Planas R; Viñado B; Riba J; Cabré E; Santos J; Luque T; Ausina V; Gassull MA
    Hepatology; 2000 Apr; 31(4):858-63. PubMed ID: 10733540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.
    Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J
    Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
    Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
    Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl
    Xu H; Xiong J; Xu J; Li S; Zhou Y; Chen D; Cai X; Ping J; Deng M; Chen J
    Dig Dis Sci; 2017 Oct; 62(10):2801-2811. PubMed ID: 28815345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats.
    Sánchez E; Soriano G; Mirelis B; Gonzalez B; Nieto JC; Vidal S; Guarner-Argente C; Juárez C; Monés J; Guarner C
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):570-6. PubMed ID: 25822866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisapride prevents enteric bacterial overgrowth and translocation by improvement of intestinal motility in rats with acute liver failure.
    Wang XD; Soltesz V; Andersson R
    Eur Surg Res; 1996; 28(6):402-12. PubMed ID: 8954316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation.
    Xie YR; Liu SL; Liu X; Luo ZB; Zhu B; Li ZF; Li LJ; He Y; Jiang L; Li H; Ruan B
    Transplant Proc; 2011 Dec; 43(10):3973-9. PubMed ID: 22172882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
    Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
    Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
    Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
    Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
    Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
    Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis.
    Veal N; Auduberteau H; Lemarie C; Oberti F; Calès P
    Dig Dis Sci; 2001 Nov; 46(11):2367-73. PubMed ID: 11713937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats.
    Chiva M; Guarner C; Peralta C; Llovet T; Gómez G; Soriano G; Balanzó J
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):145-50. PubMed ID: 12560758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.
    Gómez-Hurtado I; Moratalla A; Moya-Pérez Á; Peiró G; Zapater P; González-Navajas JM; Giménez P; Such J; Sanz Y; Francés R
    J Hepatol; 2014 Oct; 61(4):799-808. PubMed ID: 24882049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.
    Zhang W; Gu Y; Chen Y; Deng H; Chen L; Chen S; Zhang G; Gao Z
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1481-6. PubMed ID: 20739895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis.
    Fu XS; Jiang F
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):534-7. PubMed ID: 17085338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
    Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
    J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.